Photo of Colin Z. Allred
D United States House · District 32 · Texas

Rep. Colin Z. Allred

Compare
Total votes
2,168
all sessions
Attendance
99%
22 missed
Near the chamber average
With party
95%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
1,024
bills & resolutions
Higher than 87% of chamber peers
Committees
0
assignments
1,024 bills and resolutions

Sponsored bills

Total
1,024
Primary
35
Co-sponsor
989
This page
1,024
matching current filters
Co-sponsor HR 5388
In committee · United States House · Co-sponsor
PREPARE ACT of 2021

Promoting Readiness and Ensuring Proper Active pharmaceutical ingredient Reserves of Essential medicines Act of 2021 or the PREPARE Act of 2021 This bill establishes the Strategic Active Pharmaceutical Ingredient Reserve. The Department of Health and Human Services (HHS) must annually publish a public list of essential generic medicines that are medically necessary to have available at all times. HHS must report and implement a plan to establish the reserve, which must be designed to minimize the impact of an interruption or reduction in imports of (1) key starting materials (including active pharmaceutical ingredients) for essential generic medicines, and (2) finished dosage forms of essential generic medicines for which key starting materials are not imported. The plan must also contain provisions to strengthen domestic capacity for active pharmaceutical ingredient production, storage, and conversion. Within one year of this bill's enactment, the plan must include at least 25 of the essential generic medicines on the required list. The plan must add at least 25 medicines each year until the full list is covered. HHS must prioritize domestically manufactured key starting materials for the reserve to the maximum extent possible. A manufacturer of an essential generic medicine that switches to an active pharmaceutical ingredient sourced through the reserve shall not have to update the approved application for that medicine. The Government Accountability Office must report to Congress on active pharmaceutical ingredient manufacturing, including the time and costs needed to develop domestic manufacturing capabilities.

In committee Sep 28, 2021 1 co-sponsor
Co-sponsor HR 5348
In committee · United States House · Co-sponsor
ESP Family Leave Act

ESP Family Leave Act This bill allows education support professionals to meet the hours of service requirements for family and medical leave if they have worked a number of hours equal to not less than 60% of the total monthly hours expected for their job descriptions and duties, as assigned for the previous school year. Education support professionals are employees within a public school or public institution of higher education which may include specified staff, such as paraeducators, administrative support staff, custodians, skilled trade workers, and nursing support staff. The Department of Labor may provide a method for calculating such leave for these professionals.

In committee Sep 23, 2021 1 co-sponsor
Co-sponsor HRES 647
In committee · United States House · Co-sponsor
Expressing the sense of the House of Representatives that the President and the Secretary of State should ensure that the Government of Canada does not permanently store nuclear waste in the Great Lakes Basin.

This resolution expresses the sense of the House of Representatives that Canada should not allow construction of a nuclear waste repository within the Great Lakes Basin and that the President and the Department of State should work with Canada to prevent such construction and craft a long-term solution for nuclear waste storage that does not threaten the Great Lakes.

In committee Sep 17, 2021 1 co-sponsor
Co-sponsor HR 4
Passed · United States House · Co-sponsor
John R. Lewis Voting Rights Advancement Act of 2021

John R. Lewis Voting Rights Advancement Act of 2021 This bill establishes new criteria for determining which states and political subdivisions must obtain preclearance before changes to voting practices may take effect. Preclearance is the process of receiving preapproval from the Department of Justice (DOJ) or the U.S. District Court for the District of Columbia before making legal changes that would affect voting rights. A state and all of its political subdivisions shall be subject to preclearance of voting practice changes for a 10-year period if 15 or more voting rights violations occurred in the state during the previous 25 years; 10 or more violations occurred during the previous 25 years, at least 1 of which was committed by the state itself; or 3 or more violations occurred during the previous 25 years and the state administers the elections. A political subdivision as a separate unit shall also be subject to preclearance for a 10-year period if three or more voting rights violations occurred there during the previous 25 years. States and political subdivisions that meet certain thresholds regarding minority groups must preclear covered practices before implementation, such as changes to methods of election and redistricting. Further, states and political subdivisions must notify the public of changes to voting practices. Next, the bill authorizes DOJ to require states or political subdivisions to provide certain documents or answers to questions for enforcing voting rights. The bill also outlines factors courts must consider when hearing challenges to voting practices, such as the extent of any history of official voting discrimination in the state or political subdivision.

Passed Sep 14, 2021 1 co-sponsor
Co-sponsor HR 4880
In committee · United States House · Co-sponsor
Veterans’ Prostate Cancer Treatment and Research Act

Veterans' Prostate Cancer Treatment and Research Act This bill requires the Department of Veterans Affairs (VA) to establish in its National Surgery Office an interdisciplinary clinical pathway for all stages of prostate cancer. Clinical pathways are health care management tools designed around research and evidence-based practices that provide direction for the care and treatment of a specific condition. The clinical pathway must include specified elements, such as a diagnosis pathway and a treatment pathway. The VA must consult with and incorporate feedback from (1) veterans who have received prostate cancer care at its medical facilities, and (2) experts in multidisciplinary cancer care and clinical research. Additionally, the VA must publish the clinical pathway on a public VA website and annually update the pathway as needed based on medical literature and evidence-based guidelines. The bill also requires the VA to submit a plan to establish a prostate cancer program using the comprehensive prostate cancer clinical pathway.

In committee Sep 9, 2021 1 co-sponsor
Co-sponsor HR 4612
In committee · United States House · Co-sponsor
PALS Act

Protecting Access to Lifesaving Screenings Act of 2021 or the PALS Act This bill makes a series of changes relating to health insurance coverage of screening mammography. Specifically, the bill requires that any provision of law referring to current recommendations of the U.S. Preventive Services Task Force (USPSTF) with respect to breast cancer screening mammography be administered as if (1) the provision referred to USPSTF recommendations last issued before 2009; and (2) those recommendations applied to any screening mammography modality, including any digital modality of such a procedure. This requirement shall also apply to the Veterans Health Administration's policy on mammography screening for veterans. In addition, the bill preserves Medicare coverage for screening mammography, without a requirement for coinsurance, and expands the definition of screening mammography to include any digital modality of such a procedure. Further, the Centers for Medicare & Medicaid Services may not decrease the frequency with which screening mammography may be paid by Medicare for a woman over 39 years of age. In 2009, the USPSTF updated its guidelines to recommend against routine screening mammography for women between 40 to 49 years of age and to recommend biennial, instead of annual, screening mammography for most women between 50 to 74 years of age. In 2015, through the appropriations process, a three-year moratorium was placed on implementing the guidelines; the moratorium was subsequently renewed until January 1, 2023.

In committee Sep 7, 2021 1 co-sponsor
Co-sponsor HR 4328
In committee · United States House · Co-sponsor
To rename the Department of Veterans Affairs community-based outpatient clinic in San Angelo, Texas, the "Colonel Charles and JoAnne Powell VA Clinic".

This bill designates the community-based outpatient clinic of the Department of Veterans Affairs in San Angelo, Texas, as the Colonel Charles and JoAnne Powell VA Clinic.

In committee Sep 7, 2021 1 co-sponsor
Primary HR 3804
In committee · United States House · Lead sponsor
Major Medical Facility Authorization Act of 2021

Major Medical Facility Authorization Act of 2021 This bill authorizes the Department of Veterans Affairs to carry out specified major medical facility projects during FY2021. The bill also indicates the maximum amount that can be spent on each project.

In committee Sep 7, 2021 0 co-sponsors
Showing 831 to 840 of 1,024 bills
Previous 1 … 83 84 85 … 103 Next